Up to date

Technology transference

The health sector creates new business opportunities in Barcelona

They innovate in health, they have potential growth and they need an injection of capital of 200,000 Euros to 2 million Euros to go ahead with their business plans. These are the main common points of the nine Catalan companies which have presented their projects to hundreds of investors at the Barcelona Healthcare Investment Forum and the Private Investors Forum and Family Offices of IESE -a historical event with already 43 editions-. It has taken place at the main office of the Barcelona Medical Association (COMB).

15 march 2010

The Barcelona Healthcare Forum, which has been organized for second year, is promoted by entities of reference in the entrepreneurial ecosystem like Barcelona Activa together with COMB and IESE. They all share the objective of promoting the development of entrepreneurial initiatives in this sector of future.

These nine entrepreneurial projects, selected among 40 candidates, are from the area of biotechnology, medical devices, and TICs related with the health sector: Arquebio, Bioglane, Certificación de Lesiones, Dr. Healthcare, Dry Blood Spoots, Gesex Atención Domiciliaria, Pangaea Biotech, SOM Biotech and Tromobotargets.

The Network of Private Investors and Family Offices of IESE is the more active communication platform among investors and entrepreneurial people in Spain. It is formed by more than 100 employers and managers with capacity of investment. Since its creation in 2003, a total of 28 projects have been funded with a total amount of 9 million Euros. Yesterday’s session was a good opportunity for the entrepreneurial people in Catalonia. For the time being, the results of the former edition of the Healthcare Forum are that 12 companies which presented their projects, six are in process of negotiation and two have already closed funding rounds.

After the presentations, the companies’ representatives could go deep in their contacts and synergies with investors in a networking session in the same facilities.

During the day, a workshop on initiation to investment in health and biotechnology also took place. The attendees where interested in learning about investing in new projects. Also, there was a round table moderated by the founder and director of the Network of Private Investors and Family Offices of IESE, Joan Roure, where sector experts exchanged thoughts about challenges in sanitary innovation for 2010. The participants where Manel Balcells, president of the Biocat Executive Committee; Jaume Aubia, COMB managing director; Joan Bigorra, director of Innovation at the Hospital Clínic de Barcelona; Antonio Parente, CEO and cofounder of Lipotec Group and president of CataloniaBio, and Rafael Camacho, CEO of Genoma España.

Read more

Subjects of the article